Journal article : Comment
Extending treatment eligibility for chronic hepatitis B virus infection
- Abstract:
- Progress towards hepatitis B virus (HBV) elimination targets remains slow, despite efforts to support enhanced prevention, diagnosis and treatment. On the basis of insights from interventions against HIV, we argue for the wider use of antiviral therapy for HBV, highlighting the potential public health benefits in preventing liver disease and reducing transmission.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, 1.3MB, Terms of use)
-
- Publisher copy:
- 10.1038/s41575-020-00398-x
Authors
- Publisher:
- Springer Nature
- Journal:
- Nature Reviews Gastroenterology and Hepatology More from this journal
- Volume:
- 18
- Issue:
- 3
- Pages:
- 146–147
- Publication date:
- 2020-12-15
- Acceptance date:
- 2020-12-08
- DOI:
- EISSN:
-
1759-5053
- ISSN:
-
1759-5045
- Language:
-
English
- Keywords:
- Subtype:
-
Comment
- Pubs id:
-
1148333
- Local pid:
-
pubs:1148333
- Deposit date:
-
2020-12-09
Terms of use
- Copyright holder:
- Springer Nature Limited
- Copyright date:
- 2020
- Rights statement:
- © 2020, Springer Nature Limited.
- Notes:
- This is the accepted manuscript version of the article. The final version is available online from Springer Nature at: https://doi.org/10.1038/s41575-020-00398-x
If you are the owner of this record, you can report an update to it here: Report update to this record